Zobrazeno 1 - 10
of 33
pro vyhledávání: '"W. Yisak"'
Single dose pharmacodynamics of thioridazine and remoxipride in healthy younger and older volunteers
Publikováno v:
Journal of Psychopharmacology. 13:159-165
Phenothiazines are widely used in older patients, but little experimental work has been carried out in this age group. Two groups of healthy volunteers, a younger group (Y: six males and six females, aged 20-42 years) and an older group (0: six males
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba79efa1afd0931f69cfe6329181b65
https://doi.org/10.1177/026988119901300208
https://doi.org/10.1177/026988119901300208
Publikováno v:
Journal of psychopharmacology (Oxford, England). 9(2)
Fifteen healthy male volunteers received single doses of 100 mg immediate release remoxipride (IR), 150 mg controlled release remoxipride (CR), 50 mg chlorpromazine (CPZ), 2 mg lorazepam (LZ), and placebo in a randomised, five-period cross-over study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::268c09d125bc6f96a790942a1cf7d7a7
https://pubmed.ncbi.nlm.nih.gov/22298740
https://pubmed.ncbi.nlm.nih.gov/22298740
Publikováno v:
Psychopharmacology. 111:27-32
Twelve healthy male volunteers took part in a double-blind randomised cross-over study composed of three treatment sessions: remoxipride 100 mg; remoxipride 100 mg plus biperiden 4 mg; and biperiden 4 mg. Plasma and urine concentrations of remoxiprid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c3bfcaba4e8d81ba04c8851f1a7819
https://doi.org/10.1007/bf02257403
https://doi.org/10.1007/bf02257403
Publikováno v:
Acta Psychiatrica Scandinavica. 82:176-180
The pharmacokinetics of remoxipride when given as single doses of 50 mg and repeated doses of 50 mg, 100 mg, and 200 mg twice daily to 10 elderly psychotic patients (71-89 years) were compared with the findings of two other studies to reveal any age-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f533881951f2237fd7dad32d93f5ba4d
https://doi.org/10.1111/j.1600-0447.1990.tb05313.x
https://doi.org/10.1111/j.1600-0447.1990.tb05313.x
Publikováno v:
Acta Psychiatrica Scandinavica. 82:51-53
A study was undertaken in seven schizophrenic patients to evaluate the tolerability and examine the pharmacokinetics of intramuscularly administered remoxipride after a single 200 mg dose and at steady state following repeated doses of 200 mg twice d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95c58f1159eca16a45dde82bce9daaa2
https://doi.org/10.1111/j.1600-0447.1990.tb05287.x
https://doi.org/10.1111/j.1600-0447.1990.tb05287.x
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 21(1)
The pharmacokinetics of the main metabolites of cefcanel daloxate hydrochloride, a new oral cephalosporin diester prodrug, was investigated. Cefcanel is antimicrobially active. After oral administration of a single dose of [14C]cefcanel daloxate hydr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bab2674eb6caf19f4790f47eb20409df
https://pubmed.ncbi.nlm.nih.gov/8095213
https://pubmed.ncbi.nlm.nih.gov/8095213
Publikováno v:
Acta psychiatrica Scandinavica. Supplementum. 358
The interaction potential of remoxipride was investigated with biperiden, warfarin, diazepam, and ethanol. The studies were conducted in 12 healthy volunteers each of whom received single doses of remoxipride, the interacting drug, and the combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe3c4a2bd2cbf15ed0559be06801408c
https://pubmed.ncbi.nlm.nih.gov/1978492
https://pubmed.ncbi.nlm.nih.gov/1978492
Autor:
C v Bahr, M. Harring, L. Gram, A Lolke, S. Ogenstad, W. Yisak, S. Hansen, L. B. Nilsson, O.-W. Nielsen
Publikováno v:
European Neuropsychopharmacology. 1:431-432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e086b41832fdceeca04e2305343dce4
https://doi.org/10.1016/0924-977x(91)90634-7
https://doi.org/10.1016/0924-977x(91)90634-7
Publikováno v:
European Neuropsychopharmacology. 3:381
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75f9c18ed23c2807a36cde32fabe925a
https://doi.org/10.1016/0924-977x(93)90171-h
https://doi.org/10.1016/0924-977x(93)90171-h
Publikováno v:
Clinical Neuropharmacology. 15:357B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc52f0b546dc81c4b94280fee21bc957
https://doi.org/10.1097/00002826-199202001-00693
https://doi.org/10.1097/00002826-199202001-00693